Zosuquidar

Zosuquidar, also called as LY335979, a cyclopropyldibenzosuberane, was developed as an inhibitor of P-glycoprotein (P-gp). It is undergoing testing in a phase I/II trial clinical study in acute myeloid leukaemia.

Price Not Available Please inquire Zosuquidar Supplier Page

Catalog Number	167354-41-8
Alternative Name(s)	(2R)-anti-5-(3-(4-(10,11-difluoromethanodibenzo-suber-5-yl)piperazin-1-yl)2-hydroxypropoxy)quinoline trihydrochlorideLY 335979; LY-335979LY335979RS 33295-198RS-33295-198zosuquidar trihydrochloride
Molecular Formula	C32H31F2N3O2
CAS#	167354-41-8
Inchi	1S/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31?/m1/s1
Inchi Key	IHOVFYSQUDPMCN-XAKVHENESA-N
Size	Please inquire
Supplier Page	https://www.bocsci.com/product/zosuquidar-cas-167354-41-8-352692.html